Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 28Sarcoma 17Lymphoid 2Other hematologic neoplasm 1Head & Neck 1

Conditions

Oligodendroglioma 1Medulloblastoma 1Lymphoma 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 6Radiotherapy 3Fluorodeoxyglucose F18 3entrectinib 2IFL protocol 2FAPI-46 2Cisplatin 2Bevacizumab 2tipifarnib 1regorafenib 1pembrolizumab 1fluoromisonidazole 1entinostat 1cc-486 1brodalumab 1alectinib 1aflibercept 1Triiodothyronine 1Trastuzumab 1Thyroxine 1Thiotepa 1Thalidomide 1Tamoxifen 1Ritonavir 1Quality of Life 1Psychology, Positive 1Proton Therapy 1Peripheral Blood Stem Cell Transplantation 1Patient-Specific Modeling 1Patient Reported Outcome Measures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Carmustine × Head & Neck × Clear all
NCT00007982 2013-02-04

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
CNSHead & NeckLymphoid

Astrocytoma, Brain Neoplasms, Head and Neck Neoplasms, Lymphoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡